Professor of Medicine, Yale University
Oncology
Dr. Francine M. Foss, MD
|
|
Give Review
Francine M. Foss, MD practices Oncology. She attended University of Massachusetts Medical School. University of Massachusetts Medical School is ranked 49/12 in Research/PrimaryCare. She received 4 awards: "America's Top Doctors", "Top Doctors: New York Metro Area", "CMS Meaningful Use Stage 1 Certification" and "America's Top Doctors for Cancer". Dr. Francine M. Foss is also a published doctor. She has 40 paper published. The most recent paper is: Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-V chain restriction. She is registered with Medicare.
Publications
- The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal Acute GvHD.
- Cutaneous T-cell Lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
- A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral...
- Genomic landscape of cutaneous T cell Lymphoma.
- A fatal case of primary cutaneous gamma-delta T-cell Lymphoma complicated by HLH and cardiac amyloidosis.
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell Lymphoma.
- Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell Lymphoma.
- Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
- Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-hodgkin Lymphoma.
- A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and p...
- Pralatrexate: treatment of T-cell non-Hodgkin's Lymphoma.
- Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin Lymphoma.
- Genetic Polymorphisms in Oxidative Stress Pathway Genes and Modification of BMI and Risk of Non-Hodgkin Lymphoma.
- Multicenter phase II trial of temozolomide in Mycosis fungoides/Sezary syndrome: correlation with O6-methylguanine-DNA methyltransferase and mismatch repair proteins.
- Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell Lymphoma.
- Peripheral T-cell Lymphoma.
- Molecular predictors of response in aggressive T-cell Lymphomas.
- Clinical roundtable monograph. T-cell Lymphoma: therapeutic overview and disease state awareness.
- Alcohol consumption and non-Hodgkin Lymphoma survival.
- Enhancing existing approaches to peripheral T-cell Lymphoma.
- Genetic polymorphisms in the metabolic pathway and non-Hodgkin Lymphoma survival.
- The importance of accurately characterizing lymphoproliferative Disease.
- Mycosis fungoides: pathophysiology and emerging therapies.
- Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell Lymphoma.
- Biologic correlates of response and survival in patients with cutaneous T-cell Lymphoma treated with denileukin diftitox.
- The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem Cell transplantation.
- Novel agents for cutaneous T-cell Lymphoma.
- Interleukin-2 receptor-directed therapies for cutaneous Lymphomas.
- Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less Graft-versus-host disease.
- Peripheral T-cell Lymphomas: diagnosis and management.
- Extracorporeal photopheresis in the treatment of Graft-vs-host disease.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-2003. A 72-year-old man with rapidly progressive Leukemia, rash, and ...
- Persistence of host dendritic cells after transplantation is associated with Graft-versus-host disease.
- Immunologic mechanisms of extracorporeal photochemotherapy in Chronic graft-versus-host disease.
- Immunologic mechanisms of antitumor activity.
- Structure function analysis of interleukin 7: requirement for an aromatic ring at position 143 of helix D.
- Transformation in Mycosis fungoides: the role of methotrexate.
- Quality-of-life improvements in cutaneous T-cell Lymphoma patients treated with denileukin diftitox (ONTAK).
- Lymphoma of the skin.
Schools
University of Massachusetts Worcester Campus
Brigham and Women39s Hospital
National Institutes Of Health
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors: New York Metro Area
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
Education
-
National Institutes of Health Clinical Center -
Brigham and Women's Hospital -
University of Massachusetts Medical School
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1104814888 | |
| NPPES Provider LastName | FOSS | |
| NPPES Provider FirstName | FRANCINE | |
| NPPES Provider ZIPCode | 065191369 | |
| NPPES Provider State | CT | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 312.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104814888 |
| Last Name Of The Provider | FOSS |
| First Name Of The Provider | FRANCINE |
| View All |
Similar Doctors
|
|
Dr. Dennis L. Cooper, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tara B. Sanft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyndsay N. Harris, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Roy S. Herbst, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mario Sznol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart E. Seropian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah B. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard S. Hochster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven D. Gore, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|